XLO earnings: a negative outcome, -6.2%

On March 11, 2025, Xilio Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.2% in the window around the event. It had already run +33.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.